Literature DB >> 3316149

The pharmacokinetics of fusidic acid.

D S Reeves1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3316149     DOI： 10.1093/jac/20.4.467

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  20 in total

1.  A drug interaction between fusidic acid and a combination of ritonavir and saquinavir.

Authors:  Y Khaliq; K Gallicano; R Leger; B Foster; A Badley
Journal:  Br J Clin Pharmacol       Date:  2000-07       Impact factor: 4.335

2.  Compulsory reporting changing MDs' role in sexual-abuse cases.

Authors:  C Johnston
Journal:  CMAJ       Date:  1991-05-01       Impact factor: 8.262

3.  Analgesics and chronic pain: "if all you have is a hammer, every disease is a nail".

Authors:  B Goldman
Journal:  CMAJ       Date:  1991-06-15       Impact factor: 8.262

4.  Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid.

Authors:  T Norén; M Wullt; Thomas Akerlund; E Bäck; I Odenholt; L G Burman
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

5.  Effect of fusidic acid on migration and chemiluminescence of polymorphonuclear leukocytes.

Authors:  A Naess; R W Flø; C O Solberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267

6.  Fusidic acid is highly active against extracellular and intracellular Mycobacterium leprae.

Authors:  S G Franzblau; A N Biswas; E B Harris
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

7.  Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock.

Authors:  F Nicoletti; P Zaccone; R Di Marco; G Magro; S Grasso; S Morrone; A Santoni; G Tempera; P L Meroni; K Bendtzen
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

8.  Fusidic Acid Inhibits Hepatic Transporters and Metabolic Enzymes: Potential Cause of Clinical Drug-Drug Interaction Observed with Statin Coadministration.

Authors:  Anshul Gupta; Jennifer J Harris; Jianrong Lin; James P Bulgarelli; Bruce K Birmingham; Scott W Grimm
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

9.  In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay.

Authors:  H Torres; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

10.  Pharmacokinetics of intravenous fusidic acid in patients with cholestasis.

Authors:  J D Peter; F Jehl; T Pottecher; J P Dupeyron; H Monteil
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.